Literature DB >> 2909157

Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men.

M Previtali1, D Ardissino, P Barberis, C Panciroli, M Chimienti, J A Salerno.   

Abstract

Hyperventilation and ergonovine tests were carried out in a group of 30 patients with variant angina to assess the sensitivity of the 2 tests and to correlate the response with spontaneous disease activity. Hyperventilation produced a positive response in 83% (25 of 30) and ergonovine in 93% (28 of 30) of the patients. After hyperventilation 22 of 25 showed ST-segment elevation, 2 ST depression and 1 T-wave pseudonormalization; after ergonovine ST-segment elevation developed in 23 patients, ST depression in 4 and T-wave pseudonormalization in 1. In all cases the electrocardiographic changes occurred in the same leads as during the spontaneous attacks. The incidence of chest pain and ventricular arrhythmias was similar during both tests; spontaneous remission of ischemia, however, was more frequent (48 vs 14%) after hyperventilation than after ergonovine. Acute ischemia developed at a mean of 218 +/- 112 seconds after the end of hyperventilation in 19 of 25 positive tests; at that time double product was not significantly different from basal values. The sensitivity of hyperventilation was similar (95 vs 100%) to ergonovine in the patients with greater than or equal to 1 daily attack, while in those with less than 1 daily attack the sensitivity of hyperventilation decreased to 55% compared to 77% with ergonovine. Thus, in variant angina the sensitivity of both tests correlates with disease activity. Hyperventilation is a safe provocative test with a sensitivity similar to ergonovine in patients with active disease; however, in patients with sporadic attacks hyperventilation has a lower sensitivity than ergonovine and therefore a limited diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909157     DOI: 10.1016/0002-9149(89)91068-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Nutcracker, neurosis, or sampling bias?

Authors:  R M Valori
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

Review 2.  Prinzmetal's variant angina.

Authors:  S Mayer; L D Hillis
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

Review 3.  [Coronary spasm--a clinically relevant problem?].

Authors:  W Auch-Schwelk
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

4.  Coronary artery lumen complexity as a new marker for refractory symptoms in patients with vasospastic angina.

Authors:  Atsushi Tanaka; Akira Taruya; Kyosuke Shibata; Kota Fuse; Yosuke Katayama; Mao Yokoyama; Manabu Kashiwagi; Ota Shingo; Takashi Akasaka; Nobuhiro Kato
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

Review 5.  The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.

Authors:  Natalia Fabin; Maria Bergami; Edina Cenko; Raffaele Bugiardini; Olivia Manfrini
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

Review 6.  A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA).

Authors:  Alexandra Bastiany; Christine Pacheco; Tara Sedlak; Jaqueline Saw; Steven E S Miner; Shuangbo Liu; Andrea Lavoie; Daniel H Kim; Martha Gulati; Michelle M Graham
Journal:  CJC Open       Date:  2022-05-04

Review 7.  MINOCA: One Size Fits All? Probably Not-A Review of Etiology, Investigation, and Treatment.

Authors:  Lucas Lentini Herling de Oliveira; Vinícius Machado Correia; Pedro Felipe Gomes Nicz; Paulo Rogério Soares; Thiago Luis Scudeler
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

8.  Intermittent left bundle branch block caused by coronary vasospasm.

Authors:  Mohammad Alhaji
Journal:  Avicenna J Med       Date:  2013-04

Review 9.  Coronary artery spasm: review and update.

Authors:  Ming-Jui Hung; Patrick Hu; Ming-Yow Hung
Journal:  Int J Med Sci       Date:  2014-08-28       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.